OBJECTIVE: To determine whether memory tasks with demonstrated sensitivity to hippocampal function can detect variance related to preclinical Alzheimer disease (AD) biomarkers, we examined associations between performance in 3 memory tasks and CSF β-amyloid (Aβ)42/Aβ40 and phosopho-tau181 (p-tau181) in cognitively unimpaired older adults (CU). METHODS: CU enrolled in the Stanford Aging and Memory Study (n = 153; age 68.78 ± 5.81 years; 94 female) completed a lumbar puncture and memory assessments. CSF Aβ42, Aβ40, and p-tau181 were measured with the automated Lumipulse G system in a single-batch analysis. Episodic memory was assayed using a standardized delayed recall composite, paired associate (word-picture) cued recall, and a mnemonic discrimination task that involves discrimination between studied "target" objects, novel "foil" objects, and perceptually similar "lure" objects. Analyses examined cross-sectional relationships among memory performance, age, and CSF measures, controlling for sex and education. RESULTS: Age and lower Aβ42/Aβ40 were independently associated with elevated p-tau181. Age, Aβ42/Aβ40, and p-tau181 were each associated with (1) poorer associative memory and (2) diminished improvement in mnemonic discrimination performance across levels of decreased task difficulty (i.e., target-lure similarity). P-tau mediated the effect of Aβ42/Aβ40 on memory. Relationships between CSF proteins and delayed recall were similar but nonsignificant. CSF Aβ42 was not significantly associated with p-tau181 or memory. CONCLUSIONS: Tests designed to tax hippocampal function are sensitive to subtle individual differences in memory among CU and correlate with early AD-associated biomarker changes in CSF. These tests may offer utility for identifying CU with preclinical AD pathology.
OBJECTIVE: To determine whether memory tasks with demonstrated sensitivity to hippocampal function can detect variance related to preclinical Alzheimer disease (AD) biomarkers, we examined associations between performance in 3 memory tasks and CSF β-amyloid (Aβ)42/Aβ40 and phosopho-tau181 (p-tau181) in cognitively unimpaired older adults (CU). METHODS: CU enrolled in the Stanford Aging and Memory Study (n = 153; age 68.78 ± 5.81 years; 94 female) completed a lumbar puncture and memory assessments. CSF Aβ42, Aβ40, and p-tau181 were measured with the automated Lumipulse G system in a single-batch analysis. Episodic memory was assayed using a standardized delayed recall composite, paired associate (word-picture) cued recall, and a mnemonic discrimination task that involves discrimination between studied "target" objects, novel "foil" objects, and perceptually similar "lure" objects. Analyses examined cross-sectional relationships among memory performance, age, and CSF measures, controlling for sex and education. RESULTS: Age and lower Aβ42/Aβ40 were independently associated with elevated p-tau181. Age, Aβ42/Aβ40, and p-tau181 were each associated with (1) poorer associative memory and (2) diminished improvement in mnemonic discrimination performance across levels of decreased task difficulty (i.e., target-lure similarity). P-tau mediated the effect of Aβ42/Aβ40 on memory. Relationships between CSF proteins and delayed recall were similar but nonsignificant. CSF Aβ42 was not significantly associated with p-tau181 or memory. CONCLUSIONS: Tests designed to tax hippocampal function are sensitive to subtle individual differences in memory among CU and correlate with early AD-associated biomarker changes in CSF. These tests may offer utility for identifying CU with preclinical AD pathology.
Authors: Dorene M Rentz; Rebecca E Amariglio; J Alex Becker; Meghan Frey; Lauren E Olson; Katherine Frishe; Jeremy Carmasin; Jacqueline E Maye; Keith A Johnson; Reisa A Sperling Journal: Neuropsychologia Date: 2011-06-12 Impact factor: 3.139
Authors: Zachariah M Reagh; Jessica A Noche; Nicholas J Tustison; Derek Delisle; Elizabeth A Murray; Michael A Yassa Journal: Neuron Date: 2018-03-07 Impact factor: 17.173
Authors: Suzanne E Schindler; Mateusz S Jasielec; Hua Weng; Jason J Hassenstab; Ellen Grober; Lena M McCue; John C Morris; David M Holtzman; Chengjie Xiong; Anne M Fagan Journal: Neurobiol Aging Date: 2017-04-14 Impact factor: 4.673
Authors: Anja Soldan; Corinne Pettigrew; Qing Cai; Mei-Cheng Wang; Abhay R Moghekar; Richard J O'Brien; Ola A Selnes; Marilyn S Albert Journal: JAMA Neurol Date: 2016-06-01 Impact factor: 18.302
Authors: Elizabeth C Mormino; Tyler N Toueg; Carmen Azevedo; Jessica B Castillo; Wanjia Guo; Ayesha Nadiadwala; Nicole K Corso; Jacob N Hall; Audrey Fan; Alexandra N Trelle; Marc B Harrison; Madison P Hunt; Sharon J Sha; Gayle Deutsch; Michelle James; Carolyn A Fredericks; Mary Ellen Koran; Michael Zeineh; Kathleen Poston; Michael D Greicius; Mehdi Khalighi; Guido A Davidzon; Bin Shen; Greg Zaharchuk; Anthony D Wagner; Frederick T Chin Journal: Eur J Nucl Med Mol Imaging Date: 2020-06-23 Impact factor: 10.057
Authors: Dorene M Rentz; Mario A Parra Rodriguez; Rebecca Amariglio; Yaakov Stern; Reisa Sperling; Steven Ferris Journal: Alzheimers Res Ther Date: 2013-11-21 Impact factor: 6.982
Authors: Niklas Mattsson-Carlgren; Emelie Andersson; Shorena Janelidze; Rik Ossenkoppele; Philip Insel; Olof Strandberg; Henrik Zetterberg; Howard J Rosen; Gil Rabinovici; Xiyun Chai; Kaj Blennow; Jeffrey L Dage; Erik Stomrud; Ruben Smith; Sebastian Palmqvist; Oskar Hansson Journal: Sci Adv Date: 2020-04-15 Impact factor: 14.136
Authors: Andrea Castegnaro; David Howett; Adrienne Li; Elizabeth Harding; Dennis Chan; Neil Burgess; John King Journal: Hippocampus Date: 2022-08-02 Impact factor: 3.753